AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 2,495.00
+85.00 (3.53%)
At close: Aug 11, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 69.89 billion as of August 11, 2026. Its market cap has decreased by -9.19% in one year.
Market Cap
69.89B
Enterprise Value
59.68B
Revenue
331.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,495.00
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 69.89B, a decrease of -79.66%. That is a compound annual growth rate of -28.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 69.89B | -7.91% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 81.70B |
| CTCBIO | 80.45B |
| BIO-FD&C | 73.39B |
| QuadMedicine | 70.04B |
| PanGen Biotech | 69.87B |
| IMGT Co.,Ltd. | 68.33B |
| NovMetaPharma | 66.65B |
| J2KBIO | 65.43B |